BrainStorm Cell Therapeutics
BCLI
#10105
Rank
NZ$12.21 M
Marketcap
$1.87
Share price
14.87%
Change (1 day)
-86.27%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : NZ$16.04 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total liabilities are NZ$16.04 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BrainStorm Cell Therapeutics - Total liabilities on balance sheet (from 2002 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$18.05 M24.16%
2021-12-31NZ$14.54 M-33.56%
2020-12-31NZ$21.89 M-21.4%
2019-12-31NZ$27.85 M200.73%
2018-12-31NZ$9.26 M18.66%
2017-12-31NZ$7.8 M525.73%
2016-12-31NZ$1.24 M-71.08%
2015-12-31NZ$4.31 M4.43%
2014-12-31NZ$4.13 M70.81%
2013-12-31NZ$2.41 M72.07%
2012-12-31NZ$1.4 M-12.68%
2011-12-31NZ$1.6 M-19.8%
2010-12-31NZ$2 M-41.7%
2009-12-31NZ$3.44 M-32.31%
2008-12-31NZ$5.08 M10.94%
2007-12-31NZ$4.58 M27.18%
2006-12-31NZ$3.6 M
2006-03-31NZ$14.28 M5718.15%
2005-03-31NZ$0.24 M243.44%
2004-03-31NZ$0.07 M57.54%
2003-03-31NZ$0.04 M74.06%
2002-03-31NZ$0.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$66.45 B 414,124.68%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.56 B 15,917.51%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.81 B 11,194.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$18.94 B 118,004.42%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.89 B 5,451.22%๐Ÿ‡บ๐Ÿ‡ธ USA